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Autosomal dominant cataract is a clinically and genetically heterogeneous lens disorder that usually presents as
a sight-threatening trait in childhood. Here we have mapped dominant pulverulent cataract to the b-crystallin
gene cluster on chromosome 22q11.2. Suggestive evidence of linkage was detected at markers D22S1167 (LOD
score [Z] 2.09 at recombination fraction [v] 0) and D22S1154 ( at ), which closely flank the genesZp 1.39 vp 0
for bB1-crystallin (CRYBB1) and bA4-crystallin (CRYBA4). Sequencing failed to detect any nucleotide changes
in CRYBA4; however, a GrT transversion in exon 6 of CRYBB1 was found to cosegregate with cataract in the
family. This single-nucleotide change was predicted to introduce a translation stop codon at glycine 220 (G220X).
Expression of recombinant human bB1-crystallin in bacteria showed that the truncated G220X mutant was
significantly less soluble than wild type. This study has identified the first CRYBB1 mutation associated with
autosomal dominant cataract in humans.
Crystallin genes encode 195% of the water-soluble struc-
tural proteins present in the vertebrate crystalline lens,
accounting for 130% of its mass (for review, see Graw
1997). Biophysical studies have indicated that the unique
spatial arrangement and short-range ordering of the crys-
tallin proteins establish the optical transparency (Delaye
and Tardieu 1983) and high refractive index (Fernald
and Wright 1983, 1984) of the lens. At least 13 func-
tional crystallin genes have been located in the human
genome, and 11 major crystallin proteins have been iso-
lated from the human lens (Lampi et al. 1997). The latter
may be subdivided into two evolutionary distinct groups,
comprising two a-crystallins, which are members of the
small heat-shock family of proteins that function as mo-
lecular chaperones (Horwitz 1992), and nine b/g-crystal-
lins, which share a common two-domain structure com-
posed of intercalating “Greek-key” motifs (Norledge et
al. 1997). The b/g-crystallins are structurally related to a
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number of evolutionarily diverse proteins—including
bacterial spore-coat protein S, slime mold spherulin 3a,
and amphibian epidermis differentiation-specific protein—
and to the absent-in-melanoma tumor suppressor (for
review, see D’Alessio 2002).
Because of their abundant expression in the lens, crys-
tallins represent compelling candidate genes for certain
inherited forms of lens opacities, or cataracts, that usu-
ally present at birth (congenital) or during infancy and
that represent a clinically significant cause of vision loss
in childhood (Lambert and Drack 1996). So far, 10
mutations in six human crystallin genes have been as-
sociated with nonsyndromic forms of Mendelian cata-
ract, linked to 2q (He´on et al. 1999; Stephan et al. 1999;
Kmoch et al. 2000; Pande et al. 2000; Ren et al. 2000),
11q (Berry et al. 2001), 17q (Kannabiran et al. 1998;
Bateman et al. 2000), 21q (Litt et al. 1998; Pras et al.
2000), and 22q (Litt et al. 1997; Gill et al. 2000; Vanita
et al. 2001). Clinical examination of these crystallin-
related cataracts by using a slit-lamp has revealed con-
siderable inter- and intrafamilial variation with respect
to the physical location and appearance of opacities in
different developmental regions of the juvenile lens. Cen-
tral pulverulent, or powdery, opacities have been linked
with the genes CRYGC (MIM *123680), on 2q (He´on
et al. 1999), and CRYBB2 (MIM *123620), on 22q (Gill
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Figure 1 Pedigree and haplotype analysis of family ADC4,
showing segregation of four microsatellite markers (in descending or-
der from the centromere) on chromosome 22. Squares and circles
symbolize male and female individuals, respectively; blackened sym-
bols denote affected status.
Figure 2 Idiogram of chromosome 22, showing the integrated
genetic and physical order of microsatellite markers across the CRYB
gene cluster. Physical distances between markers and genes are shown.
Two-point Z values for linkage between the cataract and markers are
indicated. An asterisk denotes the intragenic marker CRYBB2-CA.
Arrows show the direction of gene transcription.
et al. 2000). Crystalline, central-nuclear, and pro-
gressive-punctate opacities have been associated with
distinct mutations in CRYGD (MIM *123690), on 2q
(Stephan et al. 1999; Pande et al. 2000). Lamellar
opacities have also been associated with CRYGC and
CRYGD mutations (Santhiya et al. 2002). Sutural
opacities, which affect the Y-shaped lines that mark
the contact of fiber cell ends at the anterior and pos-
terior poles of the fetal lens, have been linked with
mutations in CRYBA3/CRYBA1 (MIM *123610), on
17q (Kannabiran et al. 1998), and CRYBB2, on 22q
(Litt et al. 1998). Cerulean (blue-dot) opacities, which
progressively affect the cortex of the lens, have also
been associated with a mutation in CRYBB2 (Litt et
al. 1997; Vanita et al. 2001). Finally, central or nu-
clear opacities have been associated with mutations
in CRYAA (MIM *123580), on 21q (Litt et al. 1998),
whereas posterior polar cataract has been linked with
CRYAB (MIM *123590), on 11q (Berry et al. 2001). To
gain further insight about the relationships between crys-
tallin gene mutations and cataract morphology, we per-
formed linkage analysis in a four-generation family that
segregated autosomal dominant pulverulent cataract and
subsequently identified a novel mutation in the gene for
b basic 1 (bB1)–crystallin (CRYBB1 [MIM *600929]),
on 22q.
The cataract, which was bilateral in all cases, consisted
of fine, dustlike opacities that mainly affected the central
zone, or fetal nucleus, of the lens but also affected the
cortex and the anterior and posterior Y-suture regions.
Ophthalmic records confirmed that the opacities were
present from birth and that there was no family history
of other ocular or systemic abnormalities. After informed
consent was obtained, 12 members of the pedigree (fig.
1) were genotyped with microsatellite markers from the
(CA)n map (Dib et al. 1996), at two crystallin loci known
to be associated with pulverulent forms of cataract, on
2q (He´on et al. 1999) and 22q (Gill et al. 2000). From
the fully annotated chromosome 22 database (Dunham
et al. 1999) (see the Wellcome Trust Sanger Institute Web
site), we selected three framework markers that closely
flanked the four functional CRYB genes clustered on 22q
(fig. 2). In addition, we selected a (CA)15 dinucleotide
repeat marker (CRYB2-CA [GenBank accession number
X62390]) that had previously been closely associatedwith
the CRYBB2 gene (Marineau and Rouleau 1992). Align-
ment of this ∼175-bp polymorphic sequence with the en-
tire CRYBB2 gene sequence by using the BLAST algo-
rithm (Altschul et al. 1990) detected ∼100% homology
with a region of intron 3, confirming that CRYB2-CA
was an intragenic marker. First, we excluded linkage of
the cataract to CRYBB2 and CRYBB3 (MIM *123630)
with markers CRYB2-CA (LOD score [Z] 1.24 at re-
combination fraction [v] 0) and D22S1174 (Zp 1.16
at ); however, we detected positive Z values forvp 0
markers D22S1167 ( at ) and D22S1154Zp 2.09 vp 0
( at ), which flank CRYBB1 andCRYBA4Zp 1.39 vp 0
(MIM *123631) (fig. 2). Then, haplotype analysis (fig. 1)
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Figure 3 Mutation analysis of CRYBB1. A, Sequence chro-
matograms of wild-type allele, showing translation of glycine (GGA)
at codon 220. B, Sequence chromatograms of mutant allele, showing
a GrT transversion that changed glycine 220 to a stop codon (TGA).
C, Mutant allele–specific primer extension analysis. Exon 6 was am-
plified in the presence of three PCR primers (as indicated by arrows):
a sense anchor primer located in intron 5, an antisense primer located
in the 3′ UTR, and a nested antisense primer specific for the GrT
mutation in codon 220. Unaffected individuals have only the wild-
type G allele (292 bp), whereas, affected individuals also have the
mutant T allele (189 bp).D,Amino acid alignment of the fourth Greek-
key motif of bB1-crystallin (codons 193–234) with that of bB2-crys-
tallin (codons 151–192). Colons indicate identical amino acids. “X”
indicates premature-chain-termination mutations in human bB1
(G220X) and bB2 (Q155X). The locations of a missense substitution
(V187E) and an in-frame deletion (hyphens) in bB2 from the Aey2
(Graw et al. 2001) and Philly (Chambers and Russell 1991) mouse
mutants, respectively, are also indicated.
detected one affected female (IV:6) who was an obligate
recombinant at markers CRYB2-CA and D22S1174,
confirming that the disease gene was neither CRYBB2
nor CRYBB3; however, no individuals recombinant for
the cataract locus and for marker D22S1154 or marker
D22S1167 were observed, further suggesting that either
CRYBB1 or CRYBA4 was the disease gene. Finally, we
excluded linkage of the cataract to 2q with markers
D2S128 (Z p 6.90 at v p 0) and D2S157 (Z p 0.41
at ), which lie close to the CRYG gene cluster.vp 0
Alignment of the cDNA sequences for CRYBA4 (Gen-
Bank accession number NM_001886) (Lampi et al. 1997)
and CRYBB1 (GenBank accession number NM_001887)
(David et al. 1996) with the fully annotated chromo-
some 22 sequence (GenBank accession number Z95115)
(Dunham et al. 1999) confirmed that each gene com-
prised six exons and five introns, with the first exon
being a noncoding exon. Sequence analysis of all six
exons for CRYBA4, amplified using intron-specific prim-
ers (available on request), in two affected individuals
detected no significant changes from wild type (data not
shown); however, similar sequence analysis of CRYBB1
in the same affected individuals identified a GrT trans-
version in exon 6 that was not present in wild type (fig.
3). This single-nucleotide change introduced a novel
HphI site—GGTGA(N)8/9f—and was predicted to result
in a nonsense or chain-termination mutation, at codon
220, that changed a phylogenetically conserved glycine
to a stop codon (G220X). Attempts to clearly resolve
the complex heterozygous restriction-fragment pattern
for the novel HphI site on agarose gels proved unsat-
isfactory; therefore, we designed a T allele–specific PCR
primer to identify individuals heterozygous for the GrT
transversion. Primer extension analysis (fig. 3C) showed
that the T allele cosegregated with affected individuals
but not with unaffected family members. In addition,
this single-nucleotide change was not detected in a panel
of 102 normal unrelated individuals (data not shown),
suggesting that it was the causative mutation, rather than
a benign polymorphism in strong linkage disequilibrium
with the disease.
The G220X mutation was predicted to truncate wild-
type bB1-crystallin by 33 amino acids (fig. 3D). To assess
the functional effects of this premature chain termination,
we compared the inducible expression of wild-type and
G220X forms of recombinant human bB1 in Escherichia
coli. SDS-PAGE analysis detected a unique polypeptide
(band a) of molecular size ∼28 kDa in the induced soluble
fraction from E. coli transformed with wild-type bB1 (fig.
4A, lane 2). Band a was also present in the induced pellet
fraction from these bacteria but was difficult to distinguish
from a closely migrating E. coli protein (fig. 4A, lane 4).
Immunoblot analysis, using a polyclonal antibody to rat
b-crystallin (David et al. 1987), confirmed that band a
was present in the induced soluble and insoluble fractions
from bacteria transformed with wild-type bB1 (fig. 4B,
lanes 2 and 4); however, since approximately eight times
as much of the insoluble sample was analyzed as com-
pared with the soluble sample, it was estimated that al-
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Figure 4 Expression of recombinant human bB1-crystallin in
E. coli. A and B, SDS-PAGE (A) and immunoblot (B) analyses of wild-
type bB1 and G220X-bB1 in the soluble (S) and insoluble pellet (P)
fractions, before () and after () induction with IPTG. Lane M shows
molecular mass-markers; lanes 1, 3, 5, and 7 show uninduced cell
lysates, and lanes 2, 4, 6, and 8 show induced cell lysates; lanes 1, 2,
5, and 6 show soluble proteins, and lanes 3, 4, 7, and 8 show insoluble
proteins. C, MS/MS spectrum, identifying the C-terminal peptide
(HWNEW) derived from the G220X-bB1 mutant in band b excised
from the gel (lane 8) shown in panel A. The inset shows masses of
the expected fragment ions; intact N-terminal ions (b-ions) and C-
terminal ions (y-ions) that were found in the spectrum are underlined.
most all of the wild-type bB1 was soluble. In contrast,
there was no detectable induction of band a in the soluble
fraction of E. coli transformed with G220X (figs. 4A and
4B, lane 6); however, a unique immunoreactive polypep-
tide of molecular size ∼25 kDa (band b) was present in
the induced pellet fraction from these bacteria (figs. 4A
and 4B, lane 8). The b-crystallin antibody also cross-re-
acted with a closely migrating E. coli protein in all frac-
tions analyzed (fig. 2B); therefore, we used mass-spec-
trometry techniques to unequivocally identify bands a and
b as human bB1. Tryptic peptide masses derived from
band a (fig. 4A, lane 2), by using electrospray-ionization
mass spectrometry (ESI-MS), were consistent with a mo-
lecular mass of 27,890 Da (data not shown), as described
elsewhere for native bB1 (Lampi et al. 2001). Tryptic
peptide masses derived from band b by ESI-MS were con-
sistent with a truncated bB1 protein of molecular mass
24,046 Da (data not shown). Fragmentation of the pep-
tides by tandem mass spectrometry (MS/MS) identified
75% of the amino acid sequence of G220X-bB1 (En-
trez-Protein accession number NP_001878) from excised
band b (data not shown). No peptides corresponding to
the C-terminal sequence of wild-type bB1 were detected
by MS/MS; however, a peptide sequence matching the last
five C-terminal residues (215HWNEW219) predicted by the
G220X truncation (fig. 3D) was detected (fig. 4C).
Of the two other functional basic b-crystallin genes
clustered on 22q, only CRYBB2 has previously been as-
sociated with autosomal dominant cataract in humans
(Litt et al. 1997; Gill et al. 2000; Vanita et al. 2001).
CRYBB2 and CRYBB1 share ∼55% sequence identity
at the amino acid level and encode ∼14% and ∼9%,
respectively, of the total crystallins present in the new-
born human lens (Lampi et al. 1997). On the basis of
the crystallographic structure of bB2-crystallin (Nor-
ledge et al. 1997), the G220X nonsense mutation in
CRYBB1 was predicted to result in a truncated bB1 pro-
tein that lacked ∼33% of the fourth Greek-key motif
(codons 220–234; fig. 3D) and the entire C-terminal arm
(codons 235–252). Previously, a similar chain-termina-
tion mutation (Q155X) in CRYBB2 (Litt et al. 1997;
Gill et al. 2000; Vanita et al. 2001) was predicted to
remove the last 51 amino acids of the bB2 protein, ef-
fectively deleting ∼90% of fourth Greek-key motif (co-
dons 155–192; fig. 3D) and the entire C-terminal arm
(codons 193–205); however, no expression studies were
reported. Remarkably, the Q155X mutation in CRYBB2
has arisen in three geographically distinct families. Clin-
ical descriptions of the cataract morphology varied from
cerulean opacities, in an American family (Litt et al.
1997), to central and/or zonular pulverulent opacities,
in a Swiss family (Gill et al. 2000), and sutural cerulean
opacities, in an Indian family (Vanita et al. 2001). The
G220X mutation in CRYBB1 identified here was also
associated with fine punctate opacities located in the
central and sutural regions of the lens. The partial over-
lap in cataract morphology associated with the G220X
and Q155X mutations may reflect the codistribution of
bB1- and bB2-crystallins, respectively, in the high-mo-
lecular-mass octamer (Mr ∼150 kDa) fraction and the
lower-molecular-mass dimer (Mr ∼46 kDa) and trimer/
tetramer (Mr ∼71 kDa) fractions present in the human
lens (Ajaz et al. 1997; Ma et al. 1998).
Whereas bacterial expression of the G220X-bB1 mu-
tant showed that the truncated protein, lacking a C-
terminal arm and intact fourth Greek-key domain, was
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almost totally insoluble, site-directed deletion of C-ter-
minal residues from rat bB2 (Trinkl et al. 1994), chicken
bB1 (Coop et al. 1998), and human bB1 (Bateman et
al. 2001) did not significantly impair the ability of the
recombinant proteins to be solubilized from bacteria or
to form dimers in vitro. In contrast, a predicted in-frame
deletion of four amino acids (del185QSVR188) from the
fourth Greek-key motif, leaving the C-terminal arm in-
tact, rendered bB2 in the Philly mouse lens thermally
unstable and prone to abnormal aggregation (Chambers
and Russell 1991). These observations suggest that par-
tial loss of the fourth Greek-key motif, rather than trun-
cation of the C-terminal arm, is primarily responsible
for G220X-bB1 insolubility in bacteria. Significantly, the
Philly deletion was proposed to impair critical hydrogen
bonding between the third and fourth Greek-key motifs
of bB2, ultimately destabilizing the entire C-terminal do-
main. Similar instability of the G220X-bB1 mutant in
the human lens is likely to provide a potent trigger for
cataract formation.
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